Overview

  • Product name
  • Description
    Rabbit polyclonal to Bcl 7A
  • Tested applications
    Suitable for: WBmore details
  • Species reactivity
    Reacts with: Human
  • Immunogen

    Synthetic peptide conjugated to KLH, corresponding to a region within N terminal amino acids 1-30 of Human Bcl 7A (NP_001019979.1, NP_066273.1).

  • Positive control
    • NCI-H292 cell line lysates

Properties

Applications

Our Abpromise guarantee covers the use of ab107209 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Abreviews Notes
WB 1/100 - 1/500. Predicted molecular weight: 23 kDa.

Target

  • Involvement in disease
    Note=Chromosomal aberrations involving BCL7A may be a cause of B-cell non-Hodgkin lymphoma. Three-way translocation t(8;14;12)(q24.1;q32.3;q24.1) with MYC and with immunoglobulin gene regions.
  • Sequence similarities
    Belongs to the BCL7 family.
  • Post-translational
    modifications
    Phosphorylated upon DNA damage, probably by ATM or ATR.
  • Information by UniProt
  • Database links
  • Alternative names
    • B cell CLL/lymphoma 7 antibody
    • B cell CLL/lymphoma 7 protein family member A antibody
    • B cell CLL/lymphoma 7A antibody
    • B-cell CLL/lymphoma 7 protein family member A antibody
    • BCL 7 antibody
    • BCL7 antibody
    • bcl7a antibody
    • BCL7A_HUMAN antibody
    see all

Images

  • Anti-Bcl 7A antibody (ab107209) at 1/100 dilution + NCI-H292 cell line lysates at 35 µg

    Predicted band size : 23 kDa

References

ab107209 has not yet been referenced specifically in any publications.

Customer reviews and Q&As

There are currently no Customer reviews or Questions for ab107209.
Please use the links above to contact us or submit feedback about this product.

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"

Sign up